These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3390858)

  • 1. The role of genetic factors in bladder cancer.
    Schulte PA
    Cancer Detect Prev; 1988; 11(3-6):379-88. PubMed ID: 3390858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Familial bladder cancer].
    Terai A
    Nihon Rinsho; 1995 Nov; 53(11):2749-53. PubMed ID: 8538038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
    Horikawa Y; Gu J; Wu X
    Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder.
    Hein DW
    Bioessays; 1988 Dec; 9(6):200-4. PubMed ID: 3072000
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Minireview.
    Reszka E; Wasowicz W
    Neoplasma; 2002; 49(4):209-16. PubMed ID: 12382017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.
    Richter J; Jiang F; Görög JP; Sartorius G; Egenter C; Gasser TC; Moch H; Mihatsch MJ; Sauter G
    Cancer Res; 1997 Jul; 57(14):2860-4. PubMed ID: 9230190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular genetic model of human bladder cancer pathogenesis.
    Reznikoff CA; Belair CD; Yeager TR; Savelieva E; Blelloch RH; Puthenveettil JA; Cuthill S
    Semin Oncol; 1996 Oct; 23(5):571-84. PubMed ID: 8893868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
    Malats N
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation, chromosomal instability, and cancer: the schistosomiasis model.
    Rosin MP; Anwar WA; Ward AJ
    Cancer Res; 1994 Apr; 54(7 Suppl):1929s-1933s. PubMed ID: 8137314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking and chromosome 9 alterations in bladder cancer.
    Zhang ZF; Shu XM; Cordon-Cardo C; Orlow I; Lu ML; Millon TV; Cao PQ; Connolly-Jenks C; Dalbagni G; Lianes P; Lacombe L; Reuter VE; Scher H
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):321-6. PubMed ID: 9149891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of gastric cancer.
    Peddanna N; Holt S; Verma RS
    Anticancer Res; 1995; 15(5B):2055-64. PubMed ID: 8572602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
    Karahalil B; Kocabas NA; Ozçelik T
    Anticancer Res; 2006; 26(6C):4955-8. PubMed ID: 17214369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and genetic susceptibility to bladder cancer.
    Wu X; Ros MM; Gu J; Kiemeney L
    BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.